{"id":643894,"date":"2013-02-26T05:00:30","date_gmt":"2013-02-26T10:00:30","guid":{"rendered":"http:\/\/www.pehub.com\/?p=188229"},"modified":"2013-02-26T05:00:30","modified_gmt":"2013-02-26T10:00:30","slug":"nbgi-private-equity-acquires-stiplastics","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/643894","title":{"rendered":"NBGI Private Equity Acquires Stiplastics"},"content":{"rendered":"

NBGI Private Equity<\/strong> has acquired Stiplastics<\/strong> for an undisclosed sum. Stiplastics is a manufacturer of injection-molded plastic dosing, packaging solutions, and medical devices for the pharmaceutical industry including pillboxes, medication blister packs, and \u201ctamper proof\u201d systems. The Company operates production facilities in Beauvoir en Royans, France.<\/p>\n

PRESS RELEASE<\/strong><\/p>\n

NBGI Private Equity today announces the acquisition of Stiplastics (\u201cthe Company\u201d) for an undisclosed sum.
\nStiplastics is a specialist manufacturer of injection-molded plastic dosing, packaging solutions, and medical devices for the pharmaceutical industry including pillboxes, medication blister packs, and \u201ctamper proof\u201d systems. The Company employs around 70 staff and operates production facilities in Beauvoir en Royans, France.
\nStiplastics is a market leader in OTC products, including the Spoonbox\u00ae measuring spoon, containers for transporting healthcare products, measuring cups and an extensive range of Pilbox\u00ae pill dispensers. Its clients include major groups in the pharmaceutical, cosmetics and food manufacturing sectors such as Novartis, Sanofi Aventis and Danone.
\nNBGI will support the Company\u2019s existing management team, which has ambitious plans to almost double revenues in the next five years, from \u20ac12.5 million in 2012 to \u20ac23 million in 2017. The strategy is to expand Stiplastics\u2019 range of products and to leverage its reputation and relationships around the world. Over 50% of the Company\u2019s sales are generated outside of France and its local partners have already expressed strong interest in distributing the new products that are currently under development.
\nStiplastics is the third investment made from NBGI Private Equity France Fund I.
\nLaurent All\u00e9got, Investment Director, NBGI Private Equity, said: \u201cWe are delighted to back Stiplastics, and are looking forward to working with its experienced management team in capitalising on its strong international exposure and major new projects under development. The Company operates in a fragmented market and we also see it as an ideal platform from which to benefit from future consolidation.\u201d
\nJerome Empereur, CEO of Stiplastics, added: \u201cWe have ambitious plans for Stiplastics, and NBGI\u2019s deep knowledge of the sector in which we operate makes it the right partner to support us through the various stages of growth we envisage over the next few years.\u201d
\nAdvisers for NBGI on the transaction included HPML (legal); Audexo (financial due diligence) and PwC (commercial due diligence).
\nFor more information:
\nCollege Hill (PR for NBGI Private Equity) Del Jones Chantal Hadley
\nEnds
\n020 74572020 07787 183306 07585 959841<\/p>\n

The post NBGI Private Equity Acquires Stiplastics<\/a> appeared first on peHUB<\/a>.<\/p>\n

\n<\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a>\n<\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

NBGI Private Equity has acquired Stiplastics for an undisclosed sum. Stiplastics is a manufacturer of injection-molded plastic dosing, packaging solutions, and medical devices for the pharmaceutical industry including pillboxes, medication blister packs, and \u201ctamper proof\u201d systems. The Company operates production facilities in Beauvoir en Royans, France. PRESS RELEASE NBGI Private Equity today announces the acquisition […]<\/p>\n","protected":false},"author":7476,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-643894","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/643894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/7476"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=643894"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/643894\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=643894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=643894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=643894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}